Cancer Biopsy Market Report and Forecast 2024-2032

Global Cancer Biopsy Market Report and Forecast 2024-2032


Global Cancer Biopsy Market Outlook

The global cancer biopsy market size was valued at USD 28.7 billion in 2023, driven by advancements in technology and a growing preference for procedures with lower risk and discomfort across the globe. The market size is anticipated to grow at a CAGR of 13.2% during the forecast period of 2024-2032 to achieve a value of USD 87.4 billion by 2032.

Cancer Biopsy: Introduction

Cancer biopsy is a critical diagnostic procedure in oncology, involving the collection of a small sample of tissue or cells from a suspected cancerous area for examination. This sample is then analyzed under a microscope by pathologists to determine the presence and type of cancer, its aggressiveness, and other important characteristics that can guide treatment decisions. Biopsies can be performed through various methods, including needle aspiration, endoscopic biopsy, or surgical removal of tissue, depending on the location and accessibility of the tumour. The procedure is instrumental not only in confirming a cancer diagnosis but also in staging the cancer and planning an appropriate course of treatment.

In recent years, the advent of molecular and genetic testing on biopsy samples has further enhanced the diagnostic power, allowing for more personalized and targeted therapy options. Cancer biopsy remains a cornerstone in cancer management, providing vital information that shapes patient care and outcomes.

Key Trends in the Global Cancer Biopsy Market

The global Cancer Biopsy market was experiencing several key trends that were shaping its landscape. Firstly, there was an increasing shift towards minimally invasive biopsy techniques, such as liquid biopsies and fine-needle aspirations, driven by advancements in technology and a growing preference for procedures with lower risk and discomfort. Precision medicine was a significant trend, with a rising focus on molecular and genetic profiling of biopsy samples to enable more targeted and personalized cancer therapies. The integration of artificial intelligence and machine learning in analyzing biopsy samples was gaining traction, enhancing diagnostic accuracy and efficiency. There was also a growing emphasis on companion diagnostics, where biopsies are used to identify specific biomarkers that can predict the efficacy of certain treatments.

While North America and Europe continued to dominate the market, regions such as Asia Pacific were witnessing rapid growth due to increasing cancer prevalence, improving healthcare infrastructure, and rising awareness. However, challenges such as the high cost of advanced biopsy procedures and the need for skilled professionals to perform and interpret biopsies were also prevalent. Overall, these trends indicated a dynamic and evolving market, reflecting the ongoing advancements and the crucial role of cancer biopsies in oncology.

Global Cancer Biopsy Market Segmentation

Market Breakup by Product and Services
  • Kits and Consumables
  • Instruments
  • Services
Market Breakup by Type
  • Needle Biopsy
  • Skin Biopsies
  • Bone Marrow Biopsies
  • Liquid Biopsies
  • Other Biopsies
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Cancer Biopsy Market Overview

The growth of the market was primarily fuelled by the increasing global incidence of cancer and the critical role of biopsies in cancer diagnosis, staging, and treatment planning. North America held a dominant position in the market, supported by advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading biotechnology and diagnostic companies. Europe also accounted for a significant share, driven by robust healthcare systems and increasing cancer awareness. The Asia Pacific region was emerging as a rapidly growing market due to rising cancer prevalence, growing healthcare infrastructure, and increasing adoption of advanced diagnostic methods. The market featured a range of biopsy techniques, including traditional surgical biopsies, minimally invasive procedures, and innovative liquid biopsies.

Advancements in precision medicine and the development of molecular and genetic profiling techniques were further propelling the market. Despite the growth, challenges such as disparities in access to advanced diagnostic facilities in low- and middle-income countries and the high cost of certain biopsy procedures persisted. Overall, the global Cancer Biopsy market was poised for continued expansion, underlined by the indispensable role of biopsies in comprehensive cancer care.

Global Cancer Biopsy Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • QIAGEN
  • Illumina, Inc.
  • ANGLE plc
  • BD (Becton, Dickinson and Company)
  • Bio-Rad Laboratories Inc.
  • Hologic, Inc.
  • BIOCEPT, INC.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Cancer Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Cancer Epidemiology Analysis – 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Cancer Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Cancer Epidemiology Forecast (2017-2032)
5.3.1 Germany Cancer Epidemiology Forecast (2017-2032)
5.3.2 France Cancer Epidemiology Forecast (2017-2032)
5.3.3 Italy Cancer Epidemiology Forecast (2017-2032)
5.3.4 Spain Cancer Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Cancer Epidemiology Forecast (2017-2032)
5.4 Japan Cancer Epidemiology Forecast (2017-2032)
6 Cancer Biopsy Market Overview – 7MM
6.1 Cancer Biopsy Market Historical Value (2017-2023)
6.2 Cancer Biopsy Market Forecast Value (2024-2032)
7 Cancer Biopsy Market Landscape – 7MM
7.1 Cancer Biopsy: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Cancer Biopsy Product Landscape
7.2.1 Analysis by Product & Services
7.2.2 Analysis by Type
8 Cancer Biopsy Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Cancer Biopsy Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Cancer Biopsy Market Segmentation – 7MM
11.1 Cancer Biopsy Market by Product and Services
11.1.1 Market Overview
11.1.2 Kits and Consumables
11.1.3 Instruments
11.1.4 Services
11.2 Cancer Biopsy Market by Type
11.2.1 Market Overview
11.2.2 Needle Biopsy
11.2.3 Skin Biopsies
11.2.4 Bone Marrow Biopsies
11.2.5 Liquid Biopsies
11.2.6 Other Biopsies
11.3 Cancer Biopsy Market by Region
11.3.1 Market Overview
11.3.2 United States
11.3.3 EU-4 and the United Kingdom
11.3.3.1 Germany
11.3.3.2 France
11.3.3.3 Italy
11.3.3.4 Spain
11.3.3.5 United Kingdom
11.3.4 Japan
12 United States Cancer Biopsy Market
12.1 Cancer Biopsy Market Historical Value (2017-2023)
12.2 Cancer Biopsy Market Forecast Value (2024-2032)
12.3 Cancer Biopsy Market by Type
12.4 Cancer Biopsy Market by Treatment Type
13 EU-4 and United Kingdom Cancer Biopsy Market
13.1 Cancer Biopsy Market Historical Value (2017-2023)
13.2 Cancer Biopsy Market Forecast Value (2024-2032)
13.3 Germany Cancer Biopsy Market Overview
13.3.1 Cancer Biopsy Market by Type
13.3.2 Cancer Biopsy Market by Treatment Type
13.4 France Cancer Biopsy Market Overview
13.4.1 Cancer Biopsy Market by Type
13.4.2 Cancer Biopsy Market by Treatment Type
13.5 Italy Cancer Biopsy Market Overview
13.5.1 Cancer Biopsy Market by Type
13.5.2 Cancer Biopsy Market by Treatment Type
13.6 Spain Cancer Biopsy Market Overview
13.6.1 Cancer Biopsy Market by Type
13.6.2 Cancer Biopsy Market by Treatment Type
13.7 United Kingdom Cancer Biopsy Market Overview
13.7.1 Cancer Biopsy Market by Type
13.7.2 Cancer Biopsy Market by Treatment Type
14 Japan Cancer Biopsy Market
14.1 Cancer Biopsy Market Historical Value (2017-2023)
14.2 Cancer Biopsy Market Forecast Value (2024-2032)
14.3 Cancer Biopsy Market by Type
14.4 Cancer Biopsy Market by Treatment Type
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 JAPAN PMDA
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding and Investment Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnerships and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 QIAGEN
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisitions
20.1.5 Certifications
20.2 Illumina, Inc.
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisitions
20.2.5 Certifications
20.3 ANGLE plc
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisitions
20.3.5 Certifications
20.4 BD (Becton, Dickinson and Company)
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisitions
20.4.5 Certifications
20.5 Bio-Rad Laboratories Inc.
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisitions
20.5.5 Certifications
20.6 Hologic, Inc.
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisitions
20.6.5 Certifications
20.7 BIOCEPT, INC.
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisitions
20.7.5 Certifications
20.8 Thermo Fisher Scientific, Inc.
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisitions
20.8.5 Certifications
20.9 F. Hoffmann-La Roche Ltd.
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisitions
20.9.5 Certifications
20.10 Danaher
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisitions
20.10.5 Certifications
21 Cancer Biopsy Market- Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings